Evidence map›Paper›PMID 41244787›Full record

ArticleFrontiers in medicine2025

Glomerular disease associated with cancer: a case series of paraneoplastic nephrotic syndrome.

Mengsi Hu, Qiqi Ma, Liguang Wang, Tingwei Zhang, Jiangong Lin, Xiaowei Yang, Zhimei Lv, Rong Wang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mengsi HuDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Qiqi MaDepartment of Nephrology, Jiangxi Medical College, The Second Affiliated Hospital, Nanchang University, Nanchang, China.
Liguang WangDepartment of Minimally Invasive Comprehensive Treatment of Cancer, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Tingwei ZhangDepartment of Nephrology, The Affiliated Taian City Central Hospital of Qingdao University, Taian, China.
Jiangong LinDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Xiaowei YangDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Zhimei LvDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Rong WangDepartment of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association between glomerular diseases and malignancies has been recognized since the 1920s. A diverse spectrum of glomerular lesions can occur in various neoplasms, including both hematologic malignancies and solid tumors. This study presents a case series of paraneoplastic nephrotic syndrome (PNS) associated with three solid tumors: ovarian cancer, pancreatic neuroendocrine tumor (NET), and bladder cancer. The occurrence of PNS is rarely reported in association with these malignancies. Notably, all patients achieved complete or partial remission without receiving corticosteroids or immunosuppressant therapy. These observations accentuate the critical role of malignancy in the pathogenesis of glomerulopathy and underscore the therapeutic primacy of oncological control in such patients.

Indexed as

bladder cancerovarian cancerpancreatic neuroendocrine tumorparaneoplastic glomerular diseaseparaneoplastic nephrotic syndrome

Identifiers

PMID41244787
PMCPMC12611924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.